Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yotaro Une"'
Publikováno v:
Kidney International Reports, Vol 7, Iss 2, Pp 177-188 (2022)
Introduction: Simplified, but effective, hyperphosphatemia treatments with novel mechanisms of action, tolerable safety profiles, and low pill burden are needed for patients undergoing hemodialysis. Tenapanor is a calcium (Ca)-free, nonmetal, nonpoly
Externí odkaz:
https://doaj.org/article/48210c61531d4a239a5482b91c800fc1
Publikováno v:
Kidney International Reports, Vol 7, Iss 2, Pp 177-188 (2022)
Introduction: Simplified, but effective, hyperphosphatemia treatments with novel mechanisms of action, tolerable safety profiles, and low pill burden are needed for patients undergoing hemodialysis. Tenapanor is a calcium (Ca)-free, nonmetal, nonpoly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c96bb8ea45901407cee80238b234079
http://www.sciencedirect.com/science/article/pii/S246802492101514X
http://www.sciencedirect.com/science/article/pii/S246802492101514X
Autor:
Tadao Akizawa, Takashi Shigematsu, Masafumi Fukagawa, Hironori Kanda, Kazuaki Ikejiri, Yotaro Une
Publikováno v:
Am J Nephrol
Introduction: Phosphate binders are used to treat hyperphosphatemia. Some patients have inappropriately controlled serum phosphorus levels, which may occur for many reasons, including a high pill burden and adverse events (AEs). Tenapanor selectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4f4b56832d0962773a56e91aa27415d
https://doi.org/10.1159/000516156
https://doi.org/10.1159/000516156
Publikováno v:
Kidney International Reports. 7:1725-1726
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43171e76fa586a49c4fe40a7949a8ad5
https://doi.org/10.1016/j.ekir.2022.05.023
https://doi.org/10.1016/j.ekir.2022.05.023